An Anti-viral Combination Study With Japanese Hepatitis C Infection (HCV) Subject

NCT01051414 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
43
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bristol-Myers Squibb